000 02763na a2200289 4500
003 PC1342
005 20210625062756.0
008 130622s2013
040 _cH12O
041 _aeng
100 _aAllo, Gonzalo
_9761
_eEndocrinología y Nutrición
100 _9763
_aEnríquez de Salamanca Lorente, Rafael
_eInstituto de Investigación i+12
_d(2013-)
100 _aMartínez Díaz-Guerra, Guillermo
_9760
_eEndocrinología y Nutrición
100 _9501
_aHawkins Carranza, Federico Gustavo
_eEndocrinología y Nutrición
100 _aMartínez, Guillermo
245 0 0 _aBone mineral density and vitamin D levels in erythropoietic protoporphyria
_h[artículo]
260 _aEndocrine,
_c2013.
300 _a44(3):803-807.
500 _aFormato Vancouver: Allo G, Garrido Astray MC, Enríquez de Salamanca R, Martínez G, Hawkins F. Bone mineral density and vitamin D levels in erythropoietic protoporphyria. Endocrine. 2013;44(3):803-7.
501 _aPMID:23536284
504 _aContiene 21 referencias y 2 tablas.
520 _aResumen: Erythropoietic protoporphyria (EPP) is a rare disease with painful cutaneous photosensitivity, in which patients are recommended to avoid sun exposure, and wear sunscreen and adequate clothing. Our aim was to study bone mineral density (BMD) and other mineral parameters, including serum 25(OH)D levels, to evaluate the impact of these measures in the follow-up of EPP patients. A cross-sectional study of ten EPP patients (median age 25; range 22-55, four males and six females), was performed evaluating clinical features, biochemical values (bone markers and serum 25 hydroxyvitamin D), and BMD. Median serum 25(OH)D level was 19.65 ng/ml [17.50; 24.80]. Four patients had 25(OH)D in insufficiency range (20-30 ng/ml) and five patients in the deficiency range (<20 ng/ml). Lumbar T-score median levels were in the osteopenia range in both females (-1.50 [-2.30; -1.0]) and males (-1.90 [-2.40; -0.70]). Also, in the female group median femoral neck T-score were in the osteopenia range (-1.20 [-1.60; -0.60]). This is the first study reporting low BMD in EPP patients. Osteoporosis, osteopenia, and vitamin D deficiency are frequent findings in EPP patients. The contribution of sunlight avoidance measures to these results remains to be clarified. Serum levels of protoporphyrins were not related to these alterations and other factors should be investigated. We suggest that the monitoring of serum vitamin D levels in EPP patients should be mandatory, as well as vitamin D and calcium supplementation.
710 _9292
_aServicio de Endocrinología y Nutrición
710 _9625
_aInstituto de Investigación imas12
856 _uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc1342.pdf
_ySolicitar documento
942 _2ddc
_cART
_n0
999 _c1342
_d1342